Vamsi Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 15.00 Cr
as on 19-12-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.37 Cr
as on 19-12-2024
- Satisfied Charges ₹ 2.00 Cr
as on 19-12-2024
- Revenue -14.72%
(FY 2022)
- Profit -32.54%
(FY 2022)
- Ebitda -3.76%
(FY 2022)
- Net Worth 206.36%
(FY 2022)
- Total Assets 8.82%
(FY 2022)
About Vamsi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 15.00 Cr.
The company currently has active open charges totaling ₹17.37 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vamsi Pharma Private Limited India is Venkatachalam Seetharaman as COMPANY SECRETARY. Prashant Garg, Keshava Madana, Ravindra Purohit, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC099814
- Company No.
099814
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jul 2015
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Mahabub Nagar, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vamsi Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Purohit  | Managing Director | 16-Jul-2015 | Current |
| Venkatachalam Seetharaman | Company Secretary | 21-Sep-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Garg | Director | 02-Sep-2022 | Current |
| Keshava Madana | Director | 16-Jul-2015 | Current |
| Madhusudan Padira | Director | 16-Jul-2015 | Current |
| Pratap Gaddam | Director | 16-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Vamsi Pharma.
Vamsi Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.72% decrease. The company also saw a substantial fall in profitability, with a 32.54% decrease in profit. The company's net worth Soared by an impressive increase of 206.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vamsi Pharma?
In 2022, Vamsi Pharma had a promoter holding of 34.39% and a public holding of 65.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Oct 2016 | ₹17.37 Cr | Open |
Reliance Capital Ltd Creation Date: 30 Nov 2015 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Vamsi Pharma?
Vamsi Pharma has a workforce of 32 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vamsi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vamsi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
